Alzheimer’s is a devastating disease, causing a decline in cognitive function that can dramatically impact a senior’s daily routine and leave them dependent on others for simple tasks. While researchers are working on a cure for this degenerative condition, some progress is being made in the form of a new preventative drug called 2-PMAP, which aims to stop Alzheimer’s before the disease has the opportunity to cause irreversible damage to the brain.
As a leading provider of Alzheimer’s care in Westfield, we’re always looking to share new information about developments and advancements taking place in the industry. Here’s a bit of insight into the 2-PMAP drug and how it can help seniors reduce their risk for Alzheimer’s.
- Reducing Brain Plaques (aka Amyloid Beta) – People affected by Alzheimer’s and other types of dementia often have a buildup of protein in the brain known as plaques. This protein buildup is believed to be the key in preventing Alzheimer’s from occurring in people approaching the end of middle age. If researchers can find a way to stop plaque buildup in the brain, they may be able to stop Alzheimer’s from emerging.
- Blocking the Production of Amyloid Beta – Stopping amyloid beta right in its tracks is exactly what 2-PMAP is designed to do. 2-PMAP is a drug that works by preventing the production of a major protein that leads to the creation of amyloid beta in the brain. When this protein isn’t present, amyloid beta cannot be produced, thereby possibly preventing the onset of Alzheimer’s.
- Reducing Amyloid Beta in Genetically Engineered Lab Mice – Research scientists have been studying 2-PMAP using lab mice engineered to have mutations similar to Alzheimer’s in humans. After a five-day treatment with 2-PMAP, amyloid beta was reduced in the mice’s brain by 50%. After four months of treatment, the mice showed no signs of mental dysfunction that normally occurs as they age.
Although study results in animals don’t always translate well in humans, this new drug shows a lot of promise towards preventing Alzheimer’s and reducing the need for Alzheimer’s and dementia care in Westfield and throughout the United States. Researchers continue to study the drug to increase its effectiveness with the hopes of reducing the overall number of Alzheimer’s patients, which is expected to reach 15 million by the year 2050.
If you have an aging parent or loved one who has recently been diagnosed with Alzheimer’s or another memory condition, reach out to Home Care Assistance and learn how our caregivers are helping their clients live happy, healthy lives in the comfort of home. Offering hourly and 24 hour care in Westfield, as well as a unique Cognitive Therapeutics Method which aims to slow the progression of cognitive decline, we are trusted by families throughout Michigan. For more information, please call 908-450-9400 and speak with a devoted Care Manager.